Symptomatic response to GERDOFF® in patients with gastro-esophageal reflux disease and poor response to alginates: an exploratory, post-market, open-label study
Background/Aims: A novel medical device based on hyaluronic acid, chondroitin sulphate plus aluminum hydroxide (GERDOFF®, melt-in-mouth tablets) showed efficacy in reducing GER-related symptoms. This exploratory, open-label study evaluated symptomatic effects of a 14-day treatment with GERDOFF® in G...
Bewaard in:
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Turkish Society of Gastroenterology
2020-06-01
|
| Reeks: | The Turkish Journal of Gastroenterology |
| Onderwerpen: | |
| Online toegang: | https://turkjgastroenterol.org/index.php/tjg/article/view/3597 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|